| Insider-Aktien | 73.845.677 shares |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Targacept Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in TRGT / Targacept getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in TRGT / Targacept. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | 2026-05-26 | 4 | Ye Weiguo | GYRE | Common Stock | D | 6,1001 | -4.000 | -24 | 700.000 | ||||
| 2026-05-27 | 2026-05-26 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 4.000 | 3 | 704.000 | ||||
| 2026-05-27 | 2026-05-22 | 4 | Ye Weiguo | GYRE | Common Stock | D | 6,0800 | -3.500 | -21 | 700.000 | ||||
| 2026-05-27 | 2026-05-22 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 3.500 | 3 | 703.500 | ||||
| 2026-05-22 | 2026-05-21 | 4 | Ye Weiguo | GYRE | Common Stock | D | 6,1500 | -12.820 | -79 | 700.000 | ||||
| 2026-05-22 | 2026-05-21 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 12.820 | 10 | 712.820 | ||||
| 2026-05-22 | 2026-05-20 | 4 | Ye Weiguo | GYRE | Common Stock | D | 6,1500 | -9.400 | -58 | 700.000 | ||||
| 2026-05-22 | 2026-05-20 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 9.400 | 7 | 709.400 | ||||
| 2026-05-20 | 2026-05-19 | 4 | Ye Weiguo | GYRE | Common Stock | D | 6,3700 | -9.120 | -58 | 700.000 | ||||
| 2026-05-20 | 2026-05-19 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 9.120 | 7 | 709.120 | ||||
| 2026-05-20 | 2026-05-18 | 4 | Ye Weiguo | GYRE | Common Stock | D | 6,6200 | -200 | -1 | 700.000 | ||||
| 2026-05-20 | 2026-05-18 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 200 | 0 | 700.200 | ||||
| 2026-05-18 | 2026-05-15 | 4 | Ye Weiguo | GYRE | Common Stock | D | 6,6500 | -13.100 | -87 | 700.000 | ||||
| 2026-05-18 | 2026-05-15 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 13.100 | 10 | 713.100 | ||||
| 2026-05-18 | 2026-05-14 | 4 | Ye Weiguo | GYRE | Common Stock | D | 6,9100 | -15.580 | -108 | 700.000 | ||||
| 2026-05-18 | 2026-05-14 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 15.580 | 12 | 715.580 | ||||
| 2026-05-07 | 2026-05-06 | 4 | Luo Ying By Spouse | GYRE | Common Stock | I | 8,0400 | -10.136 | -81 | 2.565.226 | ||||
| 2026-05-07 | 2026-05-05 | 4 | Luo Ying By Spouse | GYRE | Common Stock | I | 8,0100 | -179 | -1 | 2.575.362 | ||||
| 2026-05-07 | 3 | Luo Ying By Spouse | GYRE | Common Stock | I | 2.575.541 | ||||||||
| 2025-05-29 | 2025-05-28 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,0700 | -558 | -6 | 2.806.084 | ||||
| 2025-05-29 | 2025-05-27 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,2800 | -2.000 | -21 | 2.806.642 | ||||
| 2025-05-27 | 2025-05-23 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,2400 | -182 | -2 | 2.808.642 | ||||
| 2025-05-27 | 2025-05-22 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,9700 | -2.000 | -22 | 2.808.824 | ||||
| 2025-05-22 | 2025-05-21 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,8300 | -2.000 | -22 | 2.810.824 | ||||
| 2025-05-22 | 2025-05-20 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,2500 | -2.000 | -22 | 2.812.824 | ||||
| 2025-05-20 | 2025-05-19 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,1100 | -2.000 | -22 | 2.814.824 | ||||
| 2025-05-20 | 2025-05-16 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,3100 | -2.000 | -23 | 2.816.824 | ||||
| 2025-05-16 | 2025-05-15 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,6800 | -2.000 | -21 | 2.818.824 | ||||
| 2025-05-16 | 2025-05-14 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,3000 | -20 | -0 | 2.820.824 | ||||
| 2025-05-14 | 2025-04-01 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 50.000 | 38 | 700.000 | ||||
| 2025-05-14 | 2025-05-13 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,3700 | -2.000 | -23 | 2.820.844 | ||||
| 2025-05-14 | 2025-05-12 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,5600 | -2.000 | -21 | 2.822.844 | ||||
| 2025-04-25 | 2025-03-27 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 150.000 | 112 | 650.000 | ||||
| 2025-04-25 | 2025-03-26 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 200.000 | 150 | 500.000 | ||||
| 2025-04-25 | 2025-03-24 | 4 | Ye Weiguo | GYRE | Common Stock | D | 0,7500 | 300.000 | 225 | 300.000 | ||||
| 2025-04-18 | 2025-04-16 | 4 | Eastling Thomas Wilson | GYRE | Common Stock | D | 6,9300 | 15.000 | 104 | 15.000 | ||||
| 2025-03-25 | 2025-03-21 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,0000 | -174 | -2 | 2.824.844 | ||||
| 2025-03-21 | 2025-03-20 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,0900 | -2.000 | -20 | 2.825.018 | ||||
| 2025-03-21 | 2025-03-19 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,1300 | -2.000 | -20 | 2.827.018 | ||||
| 2025-03-19 | 2025-03-18 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,2400 | -242 | -2 | 2.829.018 | ||||
| 2025-03-19 | 2025-03-17 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,0900 | -2.000 | -24 | 2.829.260 | ||||
| 2025-03-17 | 2025-03-14 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,3100 | -2.000 | -25 | 2.831.260 | ||||
| 2025-03-17 | 2025-03-13 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,8000 | -2.000 | -24 | 2.833.260 | ||||
| 2025-03-13 | 2025-03-12 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,7400 | -2.000 | -23 | 2.835.260 | ||||
| 2025-03-13 | 2025-03-11 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,4000 | -2.000 | -23 | 2.837.260 | ||||
| 2025-03-11 | 2025-03-10 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,1400 | -2.000 | -20 | 2.839.260 | ||||
| 2025-03-11 | 2025-03-07 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,1300 | -1.906 | -19 | 2.841.260 | ||||
| 2025-03-11 | 2025-03-07 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,1400 | -41 | -0 | 2.843.166 | ||||
| 2025-03-11 | 2025-03-07 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 13,0300 | -53 | -1 | 2.843.207 | ||||
| 2025-03-07 | 2025-03-06 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,8000 | -2.000 | -22 | 2.843.260 | ||||
| 2025-03-07 | 2025-03-05 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,9800 | -2.000 | -22 | 2.845.260 | ||||
| 2025-03-05 | 2025-03-04 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,8600 | -2.000 | -22 | 2.847.260 | ||||
| 2025-03-05 | 2025-03-03 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,2300 | -2.000 | -22 | 2.849.260 | ||||
| 2025-03-03 | 2025-02-28 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,4100 | -2.000 | -23 | 2.851.260 | ||||
| 2025-03-03 | 2025-02-27 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,3300 | -2.000 | -23 | 2.853.260 | ||||
| 2025-02-27 | 2025-02-26 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,6300 | -2.000 | -23 | 2.855.260 | ||||
| 2025-02-27 | 2025-02-25 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,3700 | -2.000 | -23 | 2.857.260 | ||||
| 2025-02-25 | 2025-02-24 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,5200 | -187 | -2 | 2.859.260 | ||||
| 2025-02-25 | 2025-02-24 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,6000 | -1.813 | -19 | 2.859.447 | ||||
| 2025-02-25 | 2025-02-21 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,6000 | -182 | -2 | 2.861.260 | ||||
| 2025-02-25 | 2025-02-21 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,8400 | -1.818 | -22 | 2.861.442 | ||||
| 2025-02-21 | 2025-02-20 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,4000 | -2.000 | -25 | 2.863.260 | ||||
| 2025-02-21 | 2025-02-19 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,2900 | -2.000 | -25 | 2.865.260 | ||||
| 2025-02-19 | 2025-02-18 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,4900 | -2.000 | -25 | 2.867.260 | ||||
| 2025-02-19 | 2025-02-14 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,9400 | -2.000 | -24 | 2.869.260 | ||||
| 2025-02-14 | 2025-02-13 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,6900 | -2.000 | -23 | 2.871.260 | ||||
| 2025-02-14 | 2025-02-12 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,4900 | -2.000 | -23 | 2.873.260 | ||||
| 2025-02-12 | 2025-02-11 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,5200 | -1.878 | -22 | 2.875.260 | ||||
| 2025-02-12 | 2025-02-10 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,9000 | -2.000 | -24 | 2.877.138 | ||||
| 2025-02-11 | 2025-02-07 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,1600 | -2.000 | -24 | 2.879.158 | ||||
| 2025-02-11 | 2025-02-06 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,8500 | -2.000 | -26 | 2.881.138 | ||||
| 2025-02-06 | 2025-02-05 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,8400 | -20 | -0 | 2.883.138 | ||||
| 2025-02-06 | 2025-02-05 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,3900 | -1.980 | -25 | 2.883.158 | ||||
| 2025-02-06 | 2025-02-04 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,6200 | -2.000 | -23 | 2.885.138 | ||||
| 2025-02-04 | 2025-02-03 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,4700 | -2.000 | -23 | 2.887.138 | ||||
| 2025-02-04 | 2025-01-31 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,5100 | -2.000 | -23 | 2.889.138 | ||||
| 2025-01-31 | 2025-01-30 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,3700 | -2.000 | -23 | 2.891.138 | ||||
| 2025-01-31 | 2025-01-29 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,4300 | -2.000 | -23 | 2.893.138 | ||||
| 2025-01-29 | 2025-01-28 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,5100 | -2.000 | -23 | 2.895.138 | ||||
| 2025-01-29 | 2025-01-27 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,1800 | -2.000 | -22 | 2.897.138 | ||||
| 2025-01-27 | 2025-01-24 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,8900 | -2.000 | -22 | 2.899.138 | ||||
| 2025-01-27 | 2025-01-23 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,4900 | -2.000 | -21 | 2.901.138 | ||||
| 2025-01-24 | 2025-01-22 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,6300 | -2.000 | -21 | 2.903.138 | ||||
| 2025-01-24 | 2025-01-21 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,8500 | -2.000 | -22 | 2.905.138 | ||||
| 2025-01-21 | 2025-01-17 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,7200 | -2.000 | -21 | 2.907.138 | ||||
| 2025-01-21 | 2025-01-16 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,7100 | -2.000 | -21 | 2.909.138 | ||||
| 2025-01-16 | 2025-01-15 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,8500 | -2.000 | -22 | 2.911.138 | ||||
| 2025-01-16 | 2025-01-14 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,3900 | -2.000 | -21 | 2.913.138 | ||||
| 2025-01-14 | 2025-01-13 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,1000 | -56 | -1 | 2.915.138 | ||||
| 2025-01-14 | 2025-01-10 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,0200 | -1.057 | -11 | 2.915.194 | ||||
| 2025-01-10 | 2025-01-03 | 4/A | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,8500 | -833 | -10 | 2.918.467 | ||||
| 2025-01-08 | 2025-01-07 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,0200 | -1.275 | -13 | 2.916.251 | ||||
| 2025-01-08 | 2025-01-06 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,1600 | -941 | -10 | 2.917.526 | ||||
| 2025-01-06 | 2025-01-03 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,0300 | -1.167 | -13 | 2.919.300 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,4000 | -2.000 | -25 | 2.920.467 | ||||
| 2025-01-06 | 2024-01-03 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,8500 | -833 | -10 | 2.918.467 | ||||
| 2025-01-02 | 2024-12-31 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,3000 | -2.000 | -25 | 2.922.467 | ||||
| 2025-01-02 | 2024-12-30 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,5000 | -2.000 | -25 | 2.924.467 | ||||
| 2024-12-30 | 2024-12-27 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,5800 | -2.000 | -25 | 2.926.467 | ||||
| 2024-12-30 | 2024-12-26 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 13,0500 | -356 | -5 | 2.928.467 | ||||
| 2024-12-30 | 2024-12-26 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,6200 | -1.644 | -21 | 2.928.823 | ||||
| 2024-12-26 | 2024-12-24 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,9300 | -2.000 | -24 | 2.930.467 | ||||
| 2024-12-26 | 2024-12-23 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,4400 | -296 | -4 | 2.932.467 | ||||
| 2024-12-26 | 2024-12-23 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,2400 | -1.704 | -21 | 2.932.763 | ||||
| 2024-12-23 | 2024-12-20 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,9000 | -2.000 | -22 | 2.934.467 | ||||
| 2024-12-23 | 2024-12-19 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,8200 | -2.000 | -22 | 2.936.467 | ||||
| 2024-12-19 | 2024-12-18 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 12,1100 | -429 | -5 | 2.938.467 | ||||
| 2024-12-19 | 2024-12-18 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,1700 | -1.571 | -18 | 2.938.896 | ||||
| 2024-12-19 | 2024-12-17 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 11,2300 | -788 | -9 | 2.940.467 | ||||
| 2024-12-19 | 2024-12-17 | 4 | Ma Songjiang By Spouse | GYRE | Common Stock | I | 10,9400 | -1.212 | -13 | 2.941.255 | ||||
| 2024-07-01 | 2024-06-28 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 12,0040 | -3.452 | -41 | 1.636 | ||||
| 2024-07-01 | 2024-06-28 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 6,9300 | 3.452 | 24 | 5.088 | ||||
| 2024-05-02 | 2024-05-01 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 15,6300 | -100 | -2 | 1.636 | ||||
| 2024-05-02 | 2024-05-01 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 14,9000 | -5.000 | -74 | 1.736 | ||||
| 2024-05-02 | 2024-05-01 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 13,8600 | -14.900 | -207 | 6.736 | ||||
| 2024-05-02 | 2024-05-01 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 6,9300 | 20.000 | 139 | 21.636 | ||||
| 2024-04-03 | 2024-04-01 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 16,1500 | -20.000 | -323 | 1.636 | ||||
| 2024-04-03 | 2024-04-01 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 6,9300 | 20.000 | 139 | 21.636 | ||||
| 2024-03-19 | 2024-03-15 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 17,2600 | -20.000 | -345 | 1.636 | ||||
| 2024-03-19 | 2024-03-15 | 4 | USMAN NASSIM | GYRE | Common Stock | D | 6,9300 | 20.000 | 139 | 21.636 | ||||
| 2023-11-22 | 3/A | Ma Songjiang By Spouse | GYRE | Common Stock | I | 2.942.467 | ||||||||
| 2023-11-22 | 2023-10-30 | 4 | GNI Group Ltd. See Remarks | GYRE | Common Stock | I | 63.588.119 | 64.005.887 | ||||||
| 2023-11-22 | 2023-10-30 | 4 | Luo Ying By Spouse | GYRE | Common Stock | I | 2.840.376 | 2.840.376 | ||||||
| 2023-10-27 | 3 | GNI Group Ltd. | CBIO | Common Stock | I | 6.266.521 | ||||||||
| 2023-10-27 | 2023-10-27 | 4 | GNI Hong Kong Ltd | CBIO | Common Stock | D | -5.371.304 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | LAWLOR AUGUSTINE By The Lawlor Family Trust UAD 4-17-00 | CBIO | Series Y Preferred Stock | I | -24 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | LAWLOR AUGUSTINE | CBIO | Series Y Preferred Stock | D | -25 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | GNI Group Ltd. | CBIO | Series Y Preferred Stock | D | -5.371 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | GNI Group Ltd. | CBIO | Series Y Preferred Stock | D | -895 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | USMAN NASSIM By Nassim Usman IRA | CBIO | Series Y Preferred Stock | I | -1 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | USMAN NASSIM By The Usman Family Trust | CBIO | Series Y Preferred Stock | I | -8 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | USMAN NASSIM | CBIO | Series Y Preferred Stock | D | -25 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | Hunt Andrea | CBIO | Series Y Preferred Stock | D | -28 | 0 | ||||||
| 2023-09-01 | 2023-08-31 | 4 | Miller Seline E. | CBIO | Series Y Preferred Stock | D | -6 | 0 | ||||||
| 2023-01-05 | 3 | GNI Hong Kong Ltd | CBIO | Common Stock | D | 895.217 | ||||||||
| 2023-01-05 | 3 | GNI Hong Kong Ltd | CBIO | Common Stock | D | 5.371.304 | ||||||||
| 2022-08-10 | 2022-08-09 | 4 | Miller Seline E. | CBIO | Common Stock | D | 0,4700 | 3.250 | 2 | 6.500 | ||||
| 2022-08-10 | 2022-08-09 | 4 | Blouse Grant E. | CBIO | Common Stock | D | 0,4700 | 3.250 | 2 | 9.417 | ||||
| 2022-08-10 | 2022-08-09 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 0,4700 | 3.250 | 2 | 24.541 | ||||
| 2022-02-23 | 2022-02-11 | 4 | Miller Seline E. | CBIO | Stock Option (Right to Buy) | D | 0,52 | 107.500 | 107.500 | |||||
| 2022-02-23 | 2022-02-11 | 4 | Blouse Grant E. | CBIO | Stock Option (Right to Buy) | D | 0,52 | 200.000 | 200.000 | |||||
| 2022-02-16 | 2022-02-09 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 0,4600 | 3.250 | 1 | 21.291 | ||||
| 2022-02-16 | 2022-02-09 | 4 | Miller Seline E. | CBIO | Common Stock | D | 0,4600 | 3.250 | 1 | 3.250 | ||||
| 2022-02-16 | 2022-02-09 | 4 | Blouse Grant E. | CBIO | Common Stock | D | 0,4600 | 3.250 | 1 | 6.167 | ||||
| 2022-01-07 | 2022-01-07 | 4 | Williams Eddie | CBIO | Common Stock | D | 12.308 | 34.804 | ||||||
| 2022-01-07 | 2022-01-07 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 12.855 | 31.790 | ||||||
| 2022-01-07 | 2022-01-07 | 4 | Hunt Andrea | CBIO | Common Stock | D | 7.521 | 28.228 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 2.980 | 22.496 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 2.858 | 18.935 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 5.839 | 24.573 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 3.588 | 29.801 | ||||||
| 2021-10-05 | 2021-10-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 1.824 | 20.707 | ||||||
| 2021-09-13 | 2021-09-09 | 4 | JEW JEANNE Y | CBIO | Stock Option (Right to Buy) | D | 4,38 | 28.000 | 28.000 | |||||
| 2021-08-11 | 2021-08-09 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 3,6200 | 867 | 3 | 18.041 | ||||
| 2021-08-11 | 2021-08-09 | 4 | Levy Howard | CBIO | Common Stock | D | 3,6200 | 639 | 2 | 639 | ||||
| 2021-08-11 | 2021-08-09 | 4 | Blouse Grant E. | CBIO | Common Stock | D | 3,6200 | 1.163 | 4 | 2.917 | ||||
| 2021-07-15 | 3 | Blouse Grant E. | CBIO | Common Stock | D | 1.754 | ||||||||
| 2021-07-02 | 2021-06-09 | 4 | TETLOW SHARON | CBIO | Stock Option (Right to Buy) | D | 4,55 | 14.000 | 14.000 | |||||
| 2021-07-02 | 2021-07-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 1.414 | 19.516 | ||||||
| 2021-07-02 | 2021-06-09 | 4 | Williams Eddie | CBIO | Stock Option (Right to Buy) | D | 4,55 | 14.000 | 14.000 | |||||
| 2021-07-02 | 2021-07-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 5.542 | 18.734 | ||||||
| 2021-07-02 | 2021-06-09 | 4 | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 4,55 | 14.000 | 14.000 | |||||
| 2021-07-02 | 2021-07-01 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 2.713 | 16.077 | ||||||
| 2021-07-02 | 2021-06-09 | 4 | Ling Geoffrey M.D. | CBIO | Stock Option (Right to Buy) | D | 4,55 | 14.000 | 14.000 | |||||
| 2021-07-02 | 2021-07-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 2.886 | 18.883 | ||||||
| 2021-07-02 | 2021-06-09 | 4 | Hunt Andrea | CBIO | Stock Option (Right to Buy) | D | 4,55 | 14.000 | 14.000 | |||||
| 2021-07-02 | 2021-07-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 3.406 | 26.213 | ||||||
| 2021-07-02 | 2021-06-09 | 4 | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 4,55 | 14.000 | 14.000 | |||||
| 2021-04-26 | 2021-02-08 | 4/A | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 5,89 | 140.000 | 140.000 | |||||
| 2021-04-26 | 2021-02-08 | 4/A | Musil Clinton | CBIO | Stock Option (Right to Buy) | D | 5,89 | 54.000 | 54.000 | |||||
| 2021-04-26 | 2021-02-08 | 4/A | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 5,89 | 25.000 | 25.000 | |||||
| 2021-04-07 | 2021-04-05 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 4,63 | -5.000 | 259.783 | |||||
| 2021-04-07 | 2021-04-05 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 4,6300 | 5.000 | 23 | 17.174 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 1.215 | 18.102 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 2.331 | 13.364 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 4.761 | 13.192 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 2.926 | 22.807 | ||||||
| 2021-04-05 | 2021-04-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 2.480 | 15.997 | ||||||
| 2021-02-22 | 2021-02-09 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 4,8100 | 582 | 3 | 12.174 | ||||
| 2021-02-22 | 2021-02-09 | 4 | Levy Howard By Howard and Gillian Levy Revocable Trust dated November 21, 1994 | CBIO | Common Stock | I | 4,8100 | 1.670 | 8 | 23.390 | ||||
| 2021-02-10 | 2021-02-08 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 5,89 | 140.000 | 140.000 | |||||
| 2021-02-10 | 2021-02-08 | 4 | Musil Clinton | CBIO | Stock Option (Right to Buy) | D | 5,89 | 54.000 | 54.000 | |||||
| 2021-02-10 | 2021-02-08 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 5,89 | 25.000 | 25.000 | |||||
| 2021-01-06 | 2021-01-05 | 4 | Williams Eddie | CBIO | Common Stock | D | 940 | 16.887 | ||||||
| 2021-01-06 | 2021-01-05 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 1.782 | 11.033 | ||||||
| 2021-01-06 | 2021-01-05 | 4 | Hunt Andrea | CBIO | Common Stock | D | 1.881 | 13.517 | ||||||
| 2021-01-06 | 2021-01-05 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 3.417 | 8.431 | ||||||
| 2021-01-06 | 2021-01-05 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 2.129 | 19.881 | ||||||
| 2020-10-02 | 2020-10-01 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 2.616 | 9.251 | ||||||
| 2020-10-02 | 2020-10-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 1.380 | 15.947 | ||||||
| 2020-10-02 | 2020-10-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 5.014 | 5.014 | ||||||
| 2020-10-02 | 2020-10-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 3.125 | 17.752 | ||||||
| 2020-10-02 | 2020-10-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 2.761 | 11.636 | ||||||
| 2020-08-12 | 2020-08-10 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 4,8100 | 582 | 3 | 11.592 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Levy Howard | CBIO | Common Stock | D | 4,8100 | 1.768 | 9 | 4.268 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Musil Clinton | CBIO | Stock Option (Right to Buy) | D | 5,88 | 140.000 | 140.000 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 2.076 | 8.875 | ||||||
| 2020-07-02 | 2020-07-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 3.673 | 24.215 | ||||||
| 2020-07-02 | 2020-07-01 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 1.703 | 6.635 | ||||||
| 2020-07-02 | 2020-07-01 | 4 | TETLOW SHARON | CBIO | Common Stock | D | 1.703 | 3.635 | ||||||
| 2020-07-02 | 2020-07-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 1.011 | 14.567 | ||||||
| 2020-07-02 | 2020-07-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 2.129 | 14.627 | ||||||
| 2020-06-12 | 2020-06-11 | 4 | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 7,18 | 5.000 | 5.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Hunt Andrea | CBIO | Stock Option (Right to Buy) | D | 7,18 | 5.000 | 5.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 7,18 | 5.000 | 5.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Ling Geoffrey M.D. | CBIO | Stock Option (Right to Buy) | D | 7,18 | 5.000 | 5.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | TETLOW SHARON | CBIO | Stock Option (Right to Buy) | D | 7,18 | 5.000 | 5.000 | |||||
| 2020-06-12 | 2020-06-11 | 4 | Williams Eddie | CBIO | Stock Option (Right to Buy) | D | 7,18 | 5.000 | 5.000 | |||||
| 2020-04-03 | 2020-04-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 1.673 | 6.799 | ||||||
| 2020-04-03 | 2020-04-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 4.934 | 20.542 | ||||||
| 2020-04-03 | 2020-04-01 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 1.932 | 4.932 | ||||||
| 2020-04-03 | 2020-04-01 | 4 | TETLOW SHARON | CBIO | Common Stock | D | 1.932 | 1.932 | ||||||
| 2020-04-03 | 2020-04-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 2.717 | 13.556 | ||||||
| 2020-04-03 | 2020-04-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 2.860 | 12.498 | ||||||
| 2020-03-17 | 2020-03-16 | 4 | Levy Howard | CBIO | Common Stock | D | 4,0526 | 2.500 | 10 | 2.500 | ||||
| 2020-03-13 | 2020-03-13 | 4 | Cai Veronica | CBIO | Common Stock | D | 4,1100 | 2.000 | 8 | 7.353 | ||||
| 2020-03-13 | 2020-03-13 | 4 | Richard John P | CBIO | Common Stock | D | 3,9800 | 2.500 | 10 | 3.716 | ||||
| 2020-03-13 | 2020-03-13 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 3,9118 | 4.000 | 16 | 11.010 | ||||
| 2020-03-04 | 2020-03-04 | 4 | Williams Eddie | CBIO | Common Stock | D | 5,7800 | 2.000 | 12 | 10.839 | ||||
| 2020-02-27 | 2020-02-25 | 4 | Ling Geoffrey M.D. | CBIO | Common Stock | D | 6,2305 | 3.000 | 19 | 3.000 | ||||
| 2020-02-25 | 2020-02-25 | 4 | LAWLOR AUGUSTINE By HealthCare Ventures VIII, L.P. | CBIO | Common Stock | I | 6,1023 | -69.401 | -424 | 0 | ||||
| 2020-02-12 | 2020-02-10 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 6,2300 | 430 | 3 | 7.010 | ||||
| 2020-02-12 | 2020-02-10 | 4 | Cai Veronica | CBIO | Common Stock | D | 6,2300 | 1.678 | 10 | 5.353 | ||||
| 2020-02-12 | 2020-02-10 | 4 | Levy Howard | CBIO | Common Stock | D | 6,2300 | 1.358 | 8 | 1.358 | ||||
| 2020-01-27 | 3 | Cai Veronica | CBIO | Common Stock | D | 5.350 | ||||||||
| 2020-01-27 | 3 | Cai Veronica | CBIO | Common Stock | D | 5.350 | ||||||||
| 2020-01-27 | 3 | Cai Veronica | CBIO | Common Stock | D | 5.350 | ||||||||
| 2020-01-27 | 2019-09-16 | 4 | Cai Veronica | CBIO | Stock Option (Right to Buy) | D | 6,22 | 3.000 | 3.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | Cai Veronica | CBIO | Stock Option (Right to Buy) | D | 6,85 | 12.000 | 12.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 6,85 | 115.000 | 115.000 | |||||
| 2020-01-27 | 2020-01-23 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 6,85 | 45.000 | 45.000 | |||||
| 2020-01-17 | 2020-01-15 | 4 | Ling Geoffrey M.D. | CBIO | Stock Option (Right to Buy) | D | 7,29 | 10.000 | 10.000 | |||||
| 2020-01-17 | 2020-01-15 | 4 | TETLOW SHARON | CBIO | Stock Option (Right to Buy) | D | 7,29 | 10.000 | 10.000 | |||||
| 2020-01-02 | 2020-01-02 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 1.835 | 9.638 | ||||||
| 2020-01-02 | 2020-01-02 | 4 | Hunt Andrea | CBIO | Common Stock | D | 1.073 | 5.126 | ||||||
| 2020-01-02 | 2020-01-02 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 3.166 | 15.608 | ||||||
| 2020-01-02 | 2020-01-02 | 4 | Williams Eddie | CBIO | Common Stock | D | 1.743 | 8.839 | ||||||
| 2019-10-02 | 2019-10-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 1.489 | 4.053 | ||||||
| 2019-10-02 | 2019-10-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 2.418 | 7.096 | ||||||
| 2019-10-02 | 2019-10-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 2.545 | 7.803 | ||||||
| 2019-10-02 | 2019-10-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 4.391 | 12.442 | ||||||
| 2019-08-12 | 2019-08-12 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 6,5100 | 413 | 3 | 6.580 | ||||
| 2019-08-12 | 2019-08-12 | 4 | Payne Fletcher | CBIO | Common Stock | D | 6,5100 | 1.180 | 8 | 3.744 | ||||
| 2019-07-02 | 2019-07-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 1.036 | 2.564 | ||||||
| 2019-07-02 | 2019-07-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 2.905 | 8.051 | ||||||
| 2019-07-02 | 2019-07-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 1.642 | 4.678 | ||||||
| 2019-07-02 | 2019-07-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 1.810 | 5.258 | ||||||
| 2019-06-17 | 2019-06-13 | 4 | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 7,46 | 5.000 | 5.000 | |||||
| 2019-06-17 | 2019-06-13 | 4 | Hunt Andrea | CBIO | Stock Option (Right to Buy) | D | 7,46 | 5.000 | 5.000 | |||||
| 2019-06-17 | 2019-06-13 | 4 | Richard John P | CBIO | Stock Option (Right to Buy) | D | 7,46 | 5.000 | 5.000 | |||||
| 2019-06-17 | 2019-06-13 | 4 | Williams Eddie | CBIO | Stock Option (Right to Buy) | D | 7,46 | 5.000 | 5.000 | |||||
| 2019-06-17 | 2019-06-13 | 4 | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 7,46 | 5.000 | 5.000 | |||||
| 2019-05-28 | 2019-05-24 | 4 | Richard John P | CBIO | Common Stock | D | 8,0300 | 1.000 | 8 | 1.216 | ||||
| 2019-05-22 | 2019-05-21 | 4 | USMAN NASSIM By The Usman Family Trust | CBIO | Common Stock | I | 4.400 | 8.456 | ||||||
| 2019-05-22 | 2019-05-21 | 4 | USMAN NASSIM | CBIO | Common Stock | D | -4.400 | 6.167 | ||||||
| 2019-05-22 | 2019-05-21 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 4,6300 | 4.400 | 20 | 10.567 | ||||
| 2019-05-22 | 2019-05-20 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 4,63 | -4.400 | 264.783 | |||||
| 2019-05-22 | 2019-05-21 | 4 | Levy Howard Howard and Gillian Levy Revocable Trust dated November 21, 1994 | CBIO | Common Stock | I | -16.094 | 16.094 | ||||||
| 2019-05-22 | 2019-05-21 | 4 | Levy Howard | CBIO | Common Stock | D | 4,6300 | 4.400 | 20 | 16.094 | ||||
| 2019-05-22 | 2019-05-20 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 4,63 | -4.400 | 81.218 | |||||
| 2019-04-02 | 2019-04-01 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 1.504 | 3.448 | ||||||
| 2019-04-02 | 2019-04-01 | 4 | Hunt Andrea | CBIO | Common Stock | D | 717 | 1.528 | ||||||
| 2019-04-02 | 2019-04-01 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 2.414 | 5.146 | ||||||
| 2019-04-02 | 2019-04-01 | 4 | Williams Eddie | CBIO | Common Stock | D | 1.364 | 3.036 | ||||||
| 2019-02-13 | 2019-02-11 | 4 | Payne Fletcher | CBIO | Common Stock | D | 7,0400 | 1.002 | 7 | 3.731 | ||||
| 2019-02-13 | 2019-02-11 | 4 | Levy Howard | CBIO | Common Stock | D | 7,0400 | 2.485 | 17 | 11.867 | ||||
| 2019-02-13 | 2019-02-11 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 7,0400 | 350 | 2 | 6.167 | ||||
| 2019-02-04 | 2019-01-31 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 4,63 | -5.729 | 269.271 | |||||
| 2019-02-04 | 2019-01-31 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 4,6300 | 5.729 | 27 | 11.041 | ||||
| 2019-02-04 | 2019-02-04 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 4,63 | -1.503 | 73.497 | |||||
| 2019-02-04 | 2019-02-04 | 4 | Payne Fletcher | CBIO | Common Stock | D | 4,6300 | 1.503 | 7 | 3.230 | ||||
| 2019-02-04 | 2019-01-31 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 4,63 | -1.500 | 93.500 | |||||
| 2019-02-04 | 2019-01-31 | 4 | Levy Howard | CBIO | Common Stock | D | 4,6300 | 1.500 | 7 | 9.382 | ||||
| 2019-01-28 | 2019-01-24 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 7,97 | 35.000 | 35.000 | |||||
| 2019-01-28 | 2019-01-24 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 7,97 | 38.000 | 38.000 | |||||
| 2019-01-28 | 2019-01-24 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 7,97 | 80.000 | 80.000 | |||||
| 2019-01-03 | 2018-12-31 | 4 | DESOUZA ERROL B | CBIO | Common Stock | D | 1.703 | 1.944 | ||||||
| 2019-01-03 | 2018-12-31 | 4 | Hunt Andrea | CBIO | Common Stock | D | 811 | 811 | ||||||
| 2019-01-03 | 2018-12-31 | 4 | LAWLOR AUGUSTINE | CBIO | Common Stock | D | 2.732 | 2.732 | ||||||
| 2019-01-03 | 2018-12-31 | 4 | Williams Eddie | CBIO | Common Stock | D | 1.544 | 1.672 | ||||||
| 2018-11-27 | 2018-11-26 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 4,63 | -149 | 87.118 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Levy Howard | CBIO | Common Stock | D | 4,6300 | 149 | 1 | 7.709 | ||||
| 2018-11-16 | 2018-11-16 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 4,63 | -173 | 87.267 | |||||
| 2018-11-16 | 2018-11-16 | 4 | Levy Howard | CBIO | Common Stock | D | 11,0000 | -173 | -2 | 7.560 | ||||
| 2018-11-16 | 2018-11-16 | 4 | Levy Howard | CBIO | Common Stock | D | 4,6300 | 173 | 1 | 7.733 | ||||
| 2018-09-06 | 2018-09-06 | 4 | HILL STEPHEN A | CBIO | Common Stock | D | 10,0700 | -190 | -2 | 1.190 | ||||
| 2018-08-01 | 2018-07-30 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 9,68 | 35.000 | 35.000 | |||||
| 2018-08-01 | 2018-07-30 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 9,68 | 25.000 | 25.000 | |||||
| 2018-08-01 | 2018-07-30 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 9,68 | 75.000 | 75.000 | |||||
| 2018-07-27 | 3 | JFL Capital Management, LLC | CBIO | Catalyst Biosciences Inc common | D | 827.246 | ||||||||
| 2018-07-27 | 3 | JFL Capital Management, LLC Managed account | CBIO | Catalyst Biosciences Inc common | I | 1.022.671 | ||||||||
| 2018-07-27 | 3 | JFL Capital Management, LLC | CBIO | Catalyst Biosciences Inc common | D | 827.246 | ||||||||
| 2018-07-27 | 3 | JFL Capital Management, LLC Managed account | CBIO | Catalyst Biosciences Inc common | I | 1.022.671 | ||||||||
| 2018-07-27 | 3 | JFL Capital Management, LLC | CBIO | Catalyst Biosciences Inc common | D | 827.246 | ||||||||
| 2018-07-27 | 3 | JFL Capital Management, LLC Managed account | CBIO | Catalyst Biosciences Inc common | I | 1.022.671 | ||||||||
| 2018-06-15 | 2018-06-13 | 4 | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 24,94 | 5.000 | 5.000 | |||||
| 2018-06-15 | 2018-06-13 | 4 | HILL STEPHEN A | CBIO | Stock Option (Right to Buy) | D | 24,94 | 5.000 | 5.000 | |||||
| 2018-06-15 | 2018-06-13 | 4 | Hunt Andrea | CBIO | Stock Option (Right to Buy) | D | 24,94 | 5.000 | 5.000 | |||||
| 2018-06-15 | 2018-06-13 | 4 | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 24,94 | 5.000 | 5.000 | |||||
| 2018-06-15 | 2018-06-13 | 4 | Richard John P | CBIO | Stock Option (Right to Buy) | D | 24,94 | 5.000 | 5.000 | |||||
| 2018-06-15 | 2018-06-13 | 4 | Williams Eddie | CBIO | Stock Option (Right to Buy) | D | 24,94 | 5.000 | 5.000 | |||||
| 2018-05-04 | 2018-05-03 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 4,63 | -7.560 | 87.440 | |||||
| 2018-05-04 | 2018-05-03 | 4 | Levy Howard | CBIO | Common Stock | D | 4,6300 | 7.560 | 35 | 7.560 | ||||
| 2018-04-11 | 2018-04-09 | 4 | USMAN NASSIM By The Usman Family Trust | CBIO | Common Stock | I | 88 | 4.144 | ||||||
| 2018-04-11 | 2018-04-09 | 4 | USMAN NASSIM | CBIO | Common Stock | D | -88 | 0 | ||||||
| 2018-04-06 | 2018-04-04 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 4,63 | -88 | 274.912 | |||||
| 2018-04-06 | 2018-04-04 | 4 | USMAN NASSIM | CBIO | Common Stock | D | 4,6300 | 88 | 0 | 88 | ||||
| 2018-03-28 | 2018-03-26 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 4,63 | -59 | 74.941 | |||||
| 2018-03-28 | 2018-03-26 | 4 | Payne Fletcher | CBIO | Common Stock | D | 4,6300 | 59 | 0 | 59 | ||||
| 2018-03-21 | 2018-03-08 | 4/A | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 29,0300 | -2.233 | -65 | 305.965 | ||||
| 2018-03-21 | 2018-03-08 | 4/A | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common Stock | I | 29,0300 | -5.890 | -171 | 807.257 | ||||
| 2018-03-21 | 2018-03-08 | 4/A | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 30,0000 | -328 | -10 | 308.198 | ||||
| 2018-03-21 | 2018-03-08 | 4/A | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common Stock | I | 30,0000 | -866 | -26 | 813.147 | ||||
| 2018-03-21 | 2018-03-07 | 4/A | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 30,0000 | -2.748 | -82 | 308.526 | ||||
| 2018-03-21 | 2018-03-07 | 4/A | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common Stock | I | 30,0000 | -7.252 | -218 | 814.013 | ||||
| 2018-03-21 | 2018-03-06 | 4/A | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 31,1800 | -10.802 | -337 | 311.274 | ||||
| 2018-03-21 | 2018-03-06 | 4/A | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common Stock | I | 31,1800 | -28.498 | -889 | 821.265 | ||||
| 2018-03-21 | 2018-03-06 | 4/A | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 29,9400 | -3.617 | -108 | 322.076 | ||||
| 2018-03-21 | 2018-03-06 | 4/A | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common Stock | I | 29,9400 | -9.544 | -286 | 849.763 | ||||
| 2018-03-08 | 2018-03-08 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 29,0300 | -8.123 | -236 | 1.113.222 | ||||
| 2018-03-08 | 2018-03-08 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 30,0000 | -1.194 | -36 | 1.121.345 | ||||
| 2018-03-08 | 2018-03-07 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 30,0000 | -10.000 | -300 | 1.122.539 | ||||
| 2018-03-08 | 2018-03-06 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 31,1800 | -39.300 | -1.225 | 1.132.539 | ||||
| 2018-03-08 | 2018-03-06 | 4 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common Stock | I | 29,9400 | -13.161 | -394 | 1.171.839 | ||||
| 2018-02-22 | 2018-02-20 | 4 | DESOUZA ERROL B | CBIO | Redeemable Convertible Note | D | 137,85 | -4.679 | 0 | |||||
| 2018-02-22 | 2018-02-20 | 4 | DESOUZA ERROL B | CBIO | Redeemable Convertible Note | D | 137,85 | 0 | ||||||
| 2018-02-22 | 2018-02-20 | 4 | HILL STEPHEN A | CBIO | Redeemable Convertible Note | D | 137,85 | -21.600 | 0 | |||||
| 2018-02-22 | 2018-02-20 | 4 | HILL STEPHEN A | CBIO | Redeemable Convertible Note | D | 137,85 | 0 | ||||||
| 2018-02-22 | 2018-02-20 | 4 | Richard John P | CBIO | Redeemable Convertible Note | D | 137,85 | |||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common stock | I | 1.510.693 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common stock | I | 1.510.693 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common stock | I | 2.044.307 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common stock | I | 2.044.307 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common stock | I | 2.044.307 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common stock | I | 1.510.693 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common stock | I | 1.510.693 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common stock | I | 2.044.307 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common stock | I | 1.510.693 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common stock | I | 2.044.307 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Partners, L.P. | CBIO | Common stock | I | 2.044.307 | ||||||||
| 2018-02-15 | 3 | Flynn James E Through Deerfield Special Situations Fund, L.P. | CBIO | Common stock | I | 1.510.693 | ||||||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 4,40 | 10.000 | 10.000 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 4,40 | -10.000 | 0 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 28,20 | 500 | 500 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 28,20 | -500 | 0 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 66,00 | 450 | 450 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 66,00 | -450 | 0 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 66,00 | 550 | 550 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 66,00 | -550 | 0 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 157,20 | 197 | 197 | |||||
| 2018-01-18 | 2018-01-16 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 157,20 | -197 | 0 | |||||
| 2018-01-16 | 2018-01-12 | 4 | Levy Howard | CBIO | Stock Option(Right to Buy) | D | 15,13 | 33.000 | 33.000 | |||||
| 2018-01-16 | 2018-01-12 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 15,13 | 26.000 | 26.000 | |||||
| 2018-01-16 | 2018-01-12 | 4 | USMAN NASSIM | CBIO | Stock Option(Right to Buy) | D | 15,13 | 95.000 | 95.000 | |||||
| 2018-01-02 | 3 | Williams Eddie | CBIO | Common Stock | D | 256 | ||||||||
| 2018-01-02 | 3 | Williams Eddie | CBIO | Common Stock | D | 256 | ||||||||
| 2018-01-02 | 2018-01-02 | 4 | Williams Eddie | CBIO | Stock Option (Right to Buy) | D | 14,37 | 10.000 | 10.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Richard John P | CBIO | Redeemable Convertible Note | D | 9,19 | |||||||
| 2017-10-26 | 2017-10-25 | 4 | Hunt Andrea | CBIO | Stock Option (Right to Buy) | D | 4,72 | 10.000 | 10.000 | |||||
| 2017-07-17 | 2017-07-13 | 4 | Richard John P | CBIO | Stock Option (Right to Buy) | D | 4,40 | 10.000 | 10.000 | |||||
| 2017-07-14 | 2017-07-13 | 4 | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 4,40 | 10.000 | 10.000 | |||||
| 2017-07-14 | 2017-07-13 | 4 | HILL STEPHEN A | CBIO | Stock Option (Right to Buy) | D | 4,40 | 10.000 | 10.000 | |||||
| 2017-07-14 | 2017-07-13 | 4 | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 4,40 | 10.000 | 10.000 | |||||
| 2017-07-14 | 2017-07-13 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 4,40 | 10.000 | 10.000 | |||||
| 2017-07-12 | 2017-07-11 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 4,63 | 275.000 | 275.000 | |||||
| 2017-07-12 | 2017-07-11 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 4,63 | 75.000 | 75.000 | |||||
| 2017-07-12 | 2017-07-11 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 4,63 | 95.000 | 95.000 | |||||
| 2016-06-13 | 2016-06-09 | 4/A | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 0 | 0 | ||||||
| 2016-06-13 | 2016-06-09 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 1,88 | 7.500 | 7.500 | |||||
| 2016-06-13 | 2016-06-09 | 4 | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 1,88 | 7.500 | 7.500 | |||||
| 2016-06-13 | 2016-06-09 | 4 | HILL STEPHEN A | CBIO | Stock Option (Right to Buy) | D | 1,88 | 7.500 | 7.500 | |||||
| 2016-06-13 | 2016-06-09 | 4 | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 1,88 | 7.500 | 7.500 | |||||
| 2016-06-13 | 2016-06-09 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 1,88 | 7.500 | 7.500 | |||||
| 2016-06-13 | 2016-06-09 | 4 | Richard John P | CBIO | Stock Option (Right to Buy) | D | 1,88 | 7.500 | 7.500 | |||||
| 2016-04-19 | 2016-04-18 | 4 | Levy Howard | CBIO | Stock Option (Right to Buy) | D | 1,52 | 100.000 | 100.000 | |||||
| 2015-12-18 | 2015-12-17 | 4 | USMAN NASSIM By Nassim Usman IRA | CBIO | Common Stock | I | 2,0000 | 4.000 | 8 | 78.375 | ||||
| 2015-12-18 | 2015-12-17 | 4 | Payne Fletcher By Charles and Nancy Payne 2000 Trust | CBIO | Common Stock | I | 2,0000 | 10.000 | 20 | 25.032 | ||||
| 2015-12-18 | 2015-12-17 | 4 | HILL STEPHEN A | CBIO | Common Stock | D | 2,0300 | 5.000 | 10 | 20.711 | ||||
| 2015-12-15 | 2015-10-22 | 4/A | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-12-15 | 2015-10-22 | 4/A | HILL STEPHEN A | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-12-15 | 2015-10-22 | 4/A | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-12-15 | 2015-10-22 | 4/A | Madison Edwin | CBIO | Stock Option (Right to Buy) | D | 4,40 | 58.572 | 58.572 | |||||
| 2015-12-15 | 2015-10-22 | 4/A | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 4,40 | 28.572 | 28.572 | |||||
| 2015-12-15 | 2015-10-22 | 4/A | Richard John P | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-12-15 | 2015-10-22 | 4/A | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-12-15 | 2015-10-22 | 4/A | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 4,40 | 153.572 | 153.572 | |||||
| 2015-10-26 | 2015-10-22 | 4 | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-10-26 | 2015-10-22 | 4 | LAWLOR AUGUSTINE | CBIO | Stock Option (Right to Buy) | D | 4,40 | 8.250 | 8.250 | |||||
| 2015-10-26 | 2015-10-22 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-10-26 | 2015-10-22 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 4,40 | 8.250 | 8.250 | |||||
| 2015-10-26 | 2015-10-22 | 4 | HILL STEPHEN A | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-10-26 | 2015-10-22 | 4 | HILL STEPHEN A | CBIO | Stock Option (Right to Buy) | D | 4,40 | 8.250 | 8.250 | |||||
| 2015-10-26 | 2015-10-22 | 4 | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-10-26 | 2015-10-22 | 4 | DESOUZA ERROL B | CBIO | Stock Option (Right to Buy) | D | 4,40 | 8.250 | 8.250 | |||||
| 2015-10-26 | 2015-10-22 | 4 | Richard John P | CBIO | Stock Option (Right to Buy) | D | 4,40 | 6.750 | 6.750 | |||||
| 2015-10-26 | 2015-10-22 | 4 | Richard John P | CBIO | Stock Option (Right to Buy) | D | 4,40 | 8.250 | 8.250 | |||||
| 2015-10-26 | 2015-10-22 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 4,40 | 153.572 | 153.572 | |||||
| 2015-10-26 | 2015-10-22 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 4,40 | 71.428 | 71.428 | |||||
| 2015-10-26 | 2015-10-22 | 4 | Madison Edwin | CBIO | Stock Option (Right to Buy) | D | 4,40 | 58.572 | 58.572 | |||||
| 2015-10-26 | 2015-10-22 | 4 | Madison Edwin | CBIO | Stock Option (Right to Buy) | D | 4,40 | 71.428 | 71.428 | |||||
| 2015-10-26 | 2015-10-22 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 4,40 | 28.572 | 28.572 | |||||
| 2015-10-26 | 2015-10-22 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 4,40 | 71.428 | 71.428 | |||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII-A, L.P. | CBIO | Common Stock | I | 1.256.411 | ||||||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII-B, L.P. | CBIO | Common Stock | I | 1.212.855 | ||||||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII, L.P. | CBIO | Common Stock | I | 2.248.142 | ||||||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII, L.P. | CBIO | Common Stock | I | 2.248.142 | ||||||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII-A, L.P. | CBIO | Common Stock | I | 1.256.411 | ||||||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII-B, L.P. | CBIO | Common Stock | I | 1.212.855 | ||||||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII, L.P. | CBIO | Common Stock | I | 2.248.142 | ||||||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII-A, L.P. | CBIO | Common Stock | I | 1.256.411 | ||||||||
| 2015-08-31 | 3 | Essex Woodlands Health Ventures VIII, L.P. By Essex Woodlands Health Ventures Fund VIII-B, L.P. | CBIO | Common Stock | I | 1.212.855 | ||||||||
| 2015-08-31 | 2015-08-28 | 4 | HILL STEPHEN A | CBIO | Common Stock | D | 6,7200 | -12.146 | -82 | 15.711 | ||||
| 2015-08-20 | 2015-08-20 | 4 | USMAN NASSIM By The Usman Family Trust | CBIO | Warrant (Right to Buy) | I | 33,27 | 29 | 29 | |||||
| 2015-08-20 | 2015-08-20 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 11,52 | 22.508 | 22.508 | |||||
| 2015-08-20 | 2015-08-20 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 7,33 | 61.118 | 61.118 | |||||
| 2015-08-20 | 2015-08-20 | 4 | USMAN NASSIM | CBIO | Stock Option (Right to Buy) | D | 9,43 | 8.786 | 8.786 | |||||
| 2015-08-20 | 2015-08-20 | 4 | USMAN NASSIM By Nassim Usman IRA | CBIO | Common Stock | I | 13.528 | 74.375 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | USMAN NASSIM By The Usman Family Trust | CBIO | Common Stock | I | 60.847 | 60.847 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | SELICK HAROLD E | CBIO | Warrant (Right to Buy) | D | 33,27 | 287 | 287 | |||||
| 2015-08-20 | 2015-08-20 | 4 | SELICK HAROLD E | CBIO | Stock Option (Right to Buy) | D | 10,48 | 2.966 | 2.966 | |||||
| 2015-08-20 | 2015-08-20 | 4 | SELICK HAROLD E By Spouse | CBIO | Common Stock | I | 382 | 16.614 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | SELICK HAROLD E | CBIO | Common Stock | D | 16.232 | 16.232 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 6,03 | 14.325 | 14.325 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 7,60 | 2.440 | 2.440 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Payne Fletcher | CBIO | Stock Option (Right to Buy) | D | 7,60 | 7.320 | 7.320 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Payne Fletcher By Charles and Nancy Payne 2000 Trust | CBIO | Common Stock | I | 15.032 | 15.032 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | Madison Edwin | CBIO | Warrant (Right to Buy) | D | 33,27 | 29 | 29 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Madison Edwin | CBIO | Stock Option (Right to Buy) | D | 11,52 | 11.254 | 11.254 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Madison Edwin | CBIO | Stock Option (Right to Buy) | D | 10,48 | 6.501 | 6.501 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Madison Edwin | CBIO | Stock Option (Right to Buy) | D | 7,33 | 26.809 | 26.809 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Madison Edwin | CBIO | Stock Option (Right to Buy) | D | 9,43 | 3.820 | 3.820 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Madison Edwin | CBIO | Common Stock | D | 31.008 | 31.008 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | LAWLOR AUGUSTINE By HealthCare Ventures VIII, L.P. | CBIO | Warrant (Right to Buy) | I | 3,33 | 14.056 | 14.056 | |||||
| 2015-08-20 | 2015-08-20 | 4 | LAWLOR AUGUSTINE By HealthCare Ventures VIII, L.P. | CBIO | Warrant (Right to Buy) | I | 3,33 | 11.383 | 11.383 | |||||
| 2015-08-20 | 2015-08-20 | 4 | LAWLOR AUGUSTINE By HealthCare Ventures VIII, L.P. | CBIO | Warrant (Right to Buy) | I | 33,27 | 2.254 | 2.254 | |||||
| 2015-08-20 | 2015-08-20 | 4 | LAWLOR AUGUSTINE By HealthCare Ventures VIII, L.P. | CBIO | Common Stock | I | 1.041.024 | 1.041.024 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII-B, L.P. | CBIO | Warrant (Right to Buy) | I | 3,33 | 687 | 687 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII-A, L.P. | CBIO | Warrant (Right to Buy) | I | 3,33 | 1.580 | 1.580 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII, L.P. | CBIO | Warrant (Right to Buy) | I | 3,33 | 21.926 | 21.926 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII-B, L.P. | CBIO | Warrant (Right to Buy) | I | 3,33 | 556 | 556 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII-A, L.P. | CBIO | Warrant (Right to Buy) | I | 3,33 | 1.280 | 1.280 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII, L.P. | CBIO | Warrant (Right to Buy) | I | 3,33 | 17.757 | 17.757 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII-B, L.P. | CBIO | Warrant (Right to Buy) | I | 33,27 | 96 | 96 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII-A, L.P. | CBIO | Warrant (Right to Buy) | I | 33,27 | 220 | 220 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII, L.P. | CBIO | Warrant (Right to Buy) | I | 33,27 | 3.065 | 3.065 | |||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII-B, L.P. | CBIO | Common Stock | I | 33.503 | 1.179.352 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII-A, L.P. | CBIO | Common Stock | I | 77.059 | 1.145.849 | ||||||
| 2015-08-20 | 2015-08-20 | 4 | Himawan Jeff By Essex Woodlands Health Ventures Fund VIII, L.P. | CBIO | Common Stock | I | 1.068.790 | 1.068.790 | ||||||
| 2015-08-18 | 2015-08-14 | 4 | Rock Patrick C. | TRGT | Redeemable Convertible Note | D | 1,31 | |||||||
| 2015-08-18 | 2015-08-14 | 4 | Hodges Mauri K | TRGT | Redeemable Convertible Note | D | 1,31 | |||||||
| 2015-08-18 | 2015-08-14 | 4 | DUNTON ALAN W | TRGT | Redeemable Convertible Note | D | 1,31 | |||||||
| 2015-08-18 | 2015-08-14 | 4 | Richard John P | TRGT | Redeemable Convertible Note | D | 1,31 | |||||||
| 2015-08-18 | 2015-08-14 | 4 | HILL STEPHEN A | TRGT | Redeemable Convertible Note | D | 1,31 | |||||||
| 2015-08-18 | 2015-08-14 | 4 | DESOUZA ERROL B | TRGT | Redeemable Convertible Note | D | 1,31 | |||||||
| 2015-08-18 | 2015-08-14 | 4 | BROWN JULIA R | TRGT | Redeemable Convertible Note | D | 1,31 | |||||||
| 2015-08-18 | 2015-08-14 | 4 | BLIXT CHARLES A | TRGT | Redeemable Convertible Note | D | 1,31 | |||||||
| 2015-08-05 | 2015-08-04 | 4 | DUNTON ALAN W | TRGT | Stock Option (Right to Buy) | D | 2,35 | 12.500 | 12.500 | |||||
| 2015-08-05 | 2015-08-04 | 4 | BLIXT CHARLES A | TRGT | Stock Option (Right to Buy) | D | 2,35 | 12.500 | 12.500 | |||||
| 2015-08-05 | 2015-08-04 | 4 | BROWN JULIA R | TRGT | Stock Option (Right to Buy) | D | 2,35 | 12.500 | 12.500 | |||||
| 2014-12-18 | 3/A | Hodges Mauri K | TRGT | Common Stock | D | 41.259 | ||||||||
| 2014-12-16 | 3 | Hodges Mauri K | TRGT | Common Stock | D | 2.318 | ||||||||
| 2014-12-16 | 3 | Hodges Mauri K | TRGT | Common Stock | D | 2.318 | ||||||||
| 2014-12-12 | 2014-12-11 | 4 | Richard John P | TRGT | Common Stock | D | 10.000 | 15.333 | ||||||
| 2014-12-12 | 2014-12-11 | 4 | DESOUZA ERROL B | TRGT | Common Stock | D | 10.000 | 15.333 | ||||||
| 2014-12-12 | 2014-12-11 | 4 | BROWN JULIA R | TRGT | Common Stock | D | 10.000 | 10.000 | ||||||
| 2014-12-12 | 2014-12-11 | 4 | BLIXT CHARLES A | TRGT | Common Stock | D | 10.000 | 10.000 | ||||||
| 2014-12-12 | 2014-12-11 | 4 | DUNTON ALAN W | TRGT | Common Stock | D | 10.000 | 10.000 | ||||||
| 2014-10-21 | 2014-10-17 | 4 | Musso Alan A | TRGT | Common Stock | D | 55.000 | 57.799 | ||||||
| 2014-10-21 | 2014-10-17 | 4 | HILL STEPHEN A | TRGT | Common Stock | D | 175.000 | 195.000 | ||||||
| 2014-10-21 | 2014-10-17 | 4 | Rock Patrick C. | TRGT | Common Stock | D | 45.000 | 45.000 | ||||||
| 2014-10-21 | 2014-10-17 | 4 | Toler Steven M. | TRGT | Common Stock | D | 45.000 | 46.000 | ||||||
| 2014-06-13 | 2014-06-12 | 4 | BLIXT CHARLES A | TRGT | Stock Option (Right to Buy) | D | 4,29 | 12.500 | 12.500 | |||||
| 2014-06-13 | 2014-06-12 | 4 | BROWN JULIA R | TRGT | Stock Option (Right to Buy) | D | 4,29 | 12.500 | 12.500 | |||||
| 2014-06-13 | 2014-06-12 | 4 | DESOUZA ERROL B | TRGT | Stock Option (Right to Buy) | D | 4,29 | 12.500 | 12.500 | |||||
| 2014-06-13 | 2014-06-12 | 4 | Richard John P | TRGT | Stock Option (Right to Buy) | D | 4,29 | 17.500 | 17.500 | |||||
| 2014-06-13 | 2014-06-12 | 4 | DUNTON ALAN W | TRGT | Stock Option (Right to Buy) | D | 4,29 | 12.500 | 12.500 | |||||
| 2014-01-24 | 2014-01-23 | 4 | HILL STEPHEN A | TRGT | Stock Option (Right to Buy) | D | 4,74 | 175.000 | 175.000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Musso Alan A | TRGT | Stock Option (Right to Buy) | D | 4,74 | 55.000 | 55.000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Toler Steven M. | TRGT | Stock Option (Right to Buy) | D | 4,74 | 45.000 | 45.000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Hosford David A. | TRGT | Stock Option (Right to Buy) | D | 4,74 | 45.000 | 45.000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Rock Patrick C. | TRGT | Stock Option (Right to Buy) | D | 4,74 | 45.000 | 45.000 | |||||
| 2014-01-17 | 2014-01-08 | 4/A | Richard John P | TRGT | Common Stock, $0.001 par value per share | D | 4,31 | -10.000 | 10.000 | |||||
| 2014-01-09 | 2014-01-08 | 4 | Richard John P | TRGT | Common Stock, $0.001 par value per share | D | 4,31 | 10.000 | 10.000 | |||||
| 2013-12-05 | 2013-12-05 | 4 | BARRIS PETER J See Note 2 | TRGT | Common Stock | I | 5,1310 | -1.000 | -5 | 0 | ||||
| 2013-12-05 | 2013-12-05 | 4 | BARRETT M JAMES See Note 3 | TRGT | Common Stock | I | 5,1310 | -1.000 | -5 | 0 | ||||
| 2013-12-05 | 2013-12-03 | 4 | BARRETT M JAMES | TRGT | Director Stock Option (right to buy) | D | 4,16 | -7.500 | 0 | |||||
| 2013-12-05 | 2013-12-03 | 4 | BARRETT M JAMES | TRGT | Director Stock Option (right to buy) | D | 2,71 | -7.500 | 0 | |||||
| 2013-12-05 | 2013-12-03 | 4 | BARRETT M JAMES | TRGT | Common Stock | D | 5,3836 | -15.000 | -81 | 0 | ||||
| 2013-12-05 | 2013-12-03 | 4 | BARRETT M JAMES | TRGT | Common Stock | D | 4,1600 | 7.500 | 31 | 15.000 | ||||
| 2013-12-05 | 2013-12-03 | 4 | BARRETT M JAMES | TRGT | Common Stock | D | 2,7100 | 7.500 | 20 | 7.500 | ||||
| 2013-12-05 | 2013-12-05 | 4 | SANDELL SCOTT D See Note 2 | TRGT | Common Stock | I | 5,1310 | -1.000 | -5 | 0 | ||||
| 2013-11-22 | 2013-11-21 | 4 | BARRIS PETER J See Note 2 | TRGT | Common Stock | I | 5,1627 | -5.333 | -28 | 1.000 | ||||
| 2013-11-22 | 2013-11-21 | 4 | BARRETT M JAMES See Note 2 | TRGT | Common Stock | I | 5,1627 | -5.333 | -28 | 1.000 | ||||
| 2013-11-22 | 2013-11-21 | 4 | SANDELL SCOTT D See Note 2 | TRGT | Common Stock | I | 5,1627 | -5.333 | -28 | 1.000 | ||||
| 2013-10-01 | 2013-09-30 | 4 | Rock Patrick C. | TRGT | Common Stock, $0.001 par value per share | D | 5,31 | 100.000 | 100.000 | |||||
| 2013-06-10 | 2013-06-07 | 4 | BLIXT CHARLES A | TRGT | Stock Option (Right to Buy) | D | 5,23 | 12.500 | 12.500 | |||||
| 2013-06-10 | 2013-06-07 | 4 | BROWN JULIA R | TRGT | Stock Option (Right to Buy) | D | 5,23 | 12.500 | 12.500 | |||||
| 2013-06-10 | 2013-06-07 | 4 | SKALETSKY MARK B | TRGT | Stock Option (Right to Buy) | D | 5,23 | 17.500 | 17.500 | |||||
| 2013-06-10 | 2013-06-07 | 4 | DESOUZA ERROL B | TRGT | Stock Option (Right to Buy) | D | 5,23 | 12.500 | 12.500 | |||||
| 2013-06-10 | 2013-06-07 | 4 | Richard John P | TRGT | Stock Option (Right to Buy) | D | 5,23 | 12.500 | 12.500 | |||||
| 2013-06-10 | 2013-06-07 | 4 | DUNTON ALAN W | TRGT | Stock Option (Right to Buy) | D | 5,23 | 12.500 | 12.500 | |||||
| 2013-06-04 | 2013-06-03 | 4 | BARRIS PETER J See Note 1 | TRGT | Stock Option (Right to Buy) | I | 0,08 | -1.000 | 0 | |||||
| 2013-06-04 | 2013-06-03 | 4 | BARRIS PETER J See Note 1 | TRGT | Common Stock | I | 0,0750 | 1.000 | 0 | 6.333 | ||||
| 2013-06-04 | 2013-06-03 | 4 | BARRETT M JAMES See Note 1 | TRGT | Stock Option (Right to Buy) | I | 0,08 | -1.000 | 0 | |||||
| 2013-06-04 | 2013-06-03 | 4 | BARRETT M JAMES See Note 1 | TRGT | Common Stock | I | 0,0750 | 1.000 | 0 | 6.333 | ||||
| 2013-06-04 | 2013-06-03 | 4 | SANDELL SCOTT D See Note 1 | TRGT | Stock Option (Right to Buy) | I | 0,08 | -1.000 | 0 | |||||
| 2013-06-04 | 2013-06-03 | 4 | SANDELL SCOTT D See Note 1 | TRGT | Common Stock | I | 0,0750 | 1.000 | 0 | 6.333 | ||||
| 2013-05-13 | 2013-05-10 | 4 | BROWN JULIA R By Julia R. Brown Trust | TRGT | Common Stock | I | 5,0890 | 6.000 | 31 | 6.000 | ||||
| 2013-03-11 | 2013-03-11 | 4/A | HILL STEPHEN A | TRGT | Common Stock | D | 4,3781 | 10.000 | 44 | 20.000 | ||||
| 2013-03-11 | 2013-03-08 | 4/A | HILL STEPHEN A | TRGT | Common Stock | D | 4,4796 | 10.000 | 45 | 10.000 | ||||
| 2013-03-11 | 2013-03-11 | 4 | HILL STEPHEN A | TRGT | Common Stock | D | 4,3781 | 10.000 | 44 | 20.000 | ||||
| 2013-03-11 | 2013-03-08 | 4 | HILL STEPHEN A | TRGT | Common Stock | D | 4,4796 | 10.000 | 45 | 10.000 | ||||
| 2013-01-18 | 2013-01-17 | 4 | Musso Alan A | TRGT | Stock Option (Right to Buy) | D | 4,63 | 65.000 | 65.000 | |||||
| 2013-01-18 | 2013-01-17 | 4 | Bencherif Merouane | TRGT | Stock Option (Right to Buy) | D | 4,63 | 40.000 | 40.000 | |||||
| 2013-01-18 | 2013-01-17 | 4 | Brennan Jeffrey P | TRGT | Stock Option (Right to Buy) | D | 4,63 | 65.000 | 65.000 | |||||
| 2013-01-18 | 2013-01-17 | 4 | Zorn Peter A | TRGT | Stock Option (Right to Buy) | D | 4,63 | 65.000 | 65.000 | |||||
| 2013-01-18 | 2013-01-17 | 4 | Hodges Mauri K | TRGT | Stock Option (Right to Buy) | D | 4,63 | 40.000 | 40.000 | |||||
| 2013-01-18 | 2013-01-17 | 4 | Hicks Karen A | TRGT | Stock Option (Right to Buy) | D | 4,63 | 40.000 | 40.000 | |||||
| 2013-01-18 | 2013-01-17 | 4 | Toler Steven M. | TRGT | Stock Option (Right to Buy) | D | 4,63 | 45.000 | 45.000 | |||||
| 2013-01-18 | 2013-01-17 | 4 | Hosford David A. | TRGT | Stock Option (RIght to Buy) | D | 4,63 | 45.000 | 45.000 | |||||
| 2013-01-11 | 3 | INVESTMENT 10 LLC By Biotechnology Value Fund, L.P. | TRGT | Common Stock, $0.001 par value | I | 2.977.919 | ||||||||
| 2013-01-11 | 3 | INVESTMENT 10 LLC By Biotechnology Value Fund II, L.P. | TRGT | Common Stock, $0.001 par value | I | 1.713.907 | ||||||||
| 2013-01-11 | 3 | INVESTMENT 10 LLC By BVF Investments, L.L.C. | TRGT | Common Stock, $0.001 par value | I | 349.482 | ||||||||
| 2013-01-11 | 3 | INVESTMENT 10 LLC | TRGT | Common Stock, $0.001 par value | D | 1.130.361 | ||||||||
| 2012-12-05 | 3 | HILL STEPHEN A | TRGT | No securities are beneficially owned | D | 0 | ||||||||
| 2012-12-05 | 2012-12-03 | 4 | HILL STEPHEN A | TRGT | Stock Option (Right to Buy) | D | 4,50 | 400.000 | 400.000 | |||||
| 2012-11-20 | 2012-11-16 | 4/A | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 3,9997 | 217.000 | 868 | 1.713.907 | ||||
| 2012-11-20 | 2012-11-16 | 4/A | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 3,9997 | 378.000 | 1.512 | 2.977.919 | ||||
| 2012-11-20 | 2012-11-19 | 4 | KRAMLICH C RICHARD See Note 1 | TRGT | Stock Option (Right to Buy) | I | 0,08 | -3.333 | 0 | |||||
| 2012-11-20 | 2012-11-19 | 4 | KRAMLICH C RICHARD See Note 1 | TRGT | Common Stock | I | 0,0750 | 3.333 | 0 | 5.333 | ||||
| 2012-11-20 | 2012-11-19 | 4 | BARRIS PETER J See Note 1 | TRGT | Stock Option (Right to Buy) | I | 0,08 | -3.333 | 0 | |||||
| 2012-11-20 | 2012-11-19 | 4 | BARRIS PETER J See Note 1 | TRGT | Common Stock | I | 0,0750 | 3.333 | 0 | 5.333 | ||||
| 2012-11-20 | 2012-11-19 | 4 | SANDELL SCOTT D See Note 1 | TRGT | Stock Option (Right to Buy) | I | 0,08 | -3.333 | 0 | |||||
| 2012-11-20 | 2012-11-19 | 4 | SANDELL SCOTT D See Note 1 | TRGT | Common Stock | I | 0,0750 | 3.333 | 0 | 5.333 | ||||
| 2012-11-19 | 2012-11-16 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 5,1083 | 26.800 | 137 | 1.523.707 | ||||
| 2012-11-19 | 2012-11-16 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 5,1083 | 46.700 | 239 | 2.646.619 | ||||
| 2012-11-19 | 2012-11-14 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0000 | 444.649 | 1.779 | 1.496.907 | ||||
| 2012-11-19 | 2012-11-14 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0000 | 772.063 | 3.088 | 2.599.919 | ||||
| 2012-11-09 | 2012-11-08 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0068 | 17.400 | 70 | 1.052.258 | ||||
| 2012-11-09 | 2012-11-08 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0068 | 31.929 | 128 | 1.827.856 | ||||
| 2012-11-09 | 2012-11-07 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0812 | 8.800 | 36 | 1.034.858 | ||||
| 2012-11-09 | 2012-11-07 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0812 | 14.300 | 58 | 1.795.927 | ||||
| 2012-11-02 | 2012-11-02 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0535 | 21.500 | 87 | 1.026.058 | ||||
| 2012-11-02 | 2012-11-02 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0535 | 36.100 | 146 | 1.781.627 | ||||
| 2012-11-02 | 2012-11-01 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | CommonStock | I | 4,0465 | 23.400 | 95 | 1.004.558 | ||||
| 2012-11-02 | 2012-11-01 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0465 | 6.700 | 27 | 1.745.527 | ||||
| 2012-11-02 | 2012-10-31 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0557 | 5.300 | 21 | 981.158 | ||||
| 2012-11-02 | 2012-10-31 | 4 | BVF PARTNERS L P/IL See Explanation of Responses | TRGT | Common Stock | I | 4,0557 | 46.700 | 189 | 1.738.827 | ||||
| 2012-09-10 | 3 | LAMPERT MARK N By BVF Investments, L.L.C. | TRGT | Common Stock, $0.001 par value | I | 349.482 | ||||||||
| 2012-09-10 | 3 | LAMPERT MARK N By Biotechnology Value Fund, L.P. | TRGT | Common Stock, $0.001 par value | I | 1.692.127 | ||||||||
| 2012-09-10 | 3 | LAMPERT MARK N By Biotechnology Value Fund II, L.P. | TRGT | Common Stock, $0.001 par value | I | 975.858 | ||||||||
| 2012-08-01 | 2012-07-31 | 4 | BURRILL STEVEN By Burrill & Company LLC | TRGT | Stock Option (Right to Buy) | I | 0,08 | -4.333 | 0 | |||||
| 2012-08-01 | 2012-07-31 | 4 | BURRILL STEVEN By Burrill & Company LLC | TRGT | Common Stock | I | 0,0750 | 4.333 | 0 | 4.333 | ||||
| 2012-08-01 | 3 | Hosford David A. | TRGT | Common Stock | D | 600 | ||||||||
| 2012-06-13 | 2012-06-11 | 4 | SKALETSKY MARK B | TRGT | Stock Option (Right to Buy) | D | 4,20 | 57.500 | 57.500 | |||||
| 2012-06-11 | 2012-06-07 | 4 | BARRETT M JAMES | TRGT | Director Stock Option (Right to Buy) | D | 4,16 | 7.500 | 7.500 | |||||
| 2012-06-11 | 2012-06-08 | 4 | Richard John P By trust | TRGT | Common Stock | I | 4,1590 | 7.500 | 31 | 7.500 | ||||
| 2012-06-11 | 3 | Toler Steven M. | TRGT | Common Stock | D | 1.000 | ||||||||
| 2012-06-08 | 2012-06-07 | 4 | BLIXT CHARLES A | TRGT | Stock Option (Right to Buy) | D | 4,16 | 7.500 | 7.500 | |||||
| 2012-06-08 | 2012-06-07 | 4 | BROWN JULIA R | TRGT | Stock Option (Right to Buy) | D | 4,16 | 7.500 | 7.500 | |||||
| 2012-06-08 | 2012-06-07 | 4 | SNYDERMAN RALPH | TRGT | Stock Option (Right to Buy) | D | 4,16 | 7.500 | 7.500 | |||||
| 2012-06-08 | 2012-06-07 | 4 | BURRILL STEVEN | TRGT | Stock Option (Right to Buy) | D | 4,16 | 7.500 | 7.500 | |||||
| 2012-06-08 | 2012-06-07 | 4 | DESOUZA ERROL B | TRGT | Stock Option (Right to Buy) | D | 4,16 | 7.500 | 7.500 | |||||
| 2012-06-08 | 2012-06-07 | 4 | Richard John P | TRGT | Stock Option (Right to Buy) | D | 4,16 | 7.500 | 7.500 | |||||
| 2012-06-08 | 2012-06-07 | 4 | DUNTON ALAN W | TRGT | Stock Option (Right to Buy) | D | 4,16 | 7.500 | 7.500 | |||||
| 2012-05-22 | 2012-05-18 | 4 | Bencherif Merouane | TRGT | Stock Option (Right to Buy) | D | 2,93 | -15.938 | 7.970 | |||||
| 2012-05-22 | 2012-05-18 | 4 | Bencherif Merouane | TRGT | Common Stock | D | 2,9300 | 15.938 | 47 | 15.938 | ||||
| 2012-05-08 | 2012-05-04 | 4 | Musso Alan A | TRGT | Stock Option (Right to Buy) | D | 4,59 | 100.000 | 100.000 | |||||
| 2012-05-08 | 2012-05-04 | 4 | Bencherif Merouane | TRGT | Stock Option (Right to Buy) | D | 4,59 | 90.000 | 90.000 | |||||
| 2012-05-08 | 2012-05-04 | 4 | deBethizy J Donald | TRGT | Stock Option (Right to Buy) | D | 4,59 | 135.000 | 135.000 | |||||
| 2012-05-08 | 2012-05-04 | 4 | Brennan Jeffrey P | TRGT | Stock Option (Right to Buy) | D | 4,59 | 100.000 | 100.000 | |||||
| 2012-05-08 | 2012-05-04 | 4 | Zorn Peter A | TRGT | Stock Option (Right to Buy) | D | 4,59 | 100.000 | 100.000 | |||||
| 2012-05-08 | 2012-05-04 | 4 | Hicks Karen A | TRGT | Stock Option (Right to Buy) | D | 4,59 | 60.000 | 60.000 | |||||
| 2012-05-08 | 2012-05-04 | 4 | Hodges Mauri K | TRGT | Stock Option (Right to Buy) | D | 4,59 | 60.000 | 60.000 | |||||
| 2012-02-16 | 2012-02-14 | 4 | deBethizy J Donald | TRGT | Stock Option (Right to Buy) | D | 5,10 | -798 | 0 | |||||
| 2012-02-16 | 2012-02-14 | 4 | deBethizy J Donald | TRGT | Common Stock | D | 5,1000 | 798 | 4 | 798 | ||||
| 2010-04-22 | 3 | Hicks Karen A | TRGT | Common Stock | D | 4.226 | ||||||||
| 2010-04-22 | 3 | Hodges Mauri K | TRGT | Common Stock | D | 1.159 | ||||||||
| 2007-03-07 | 2006-10-25 | 4/A | DUNTON ALAN W | TRGT | Stock option (right to buy) | D | 5,69 | 25.000 | 25.000 | |||||
| 2007-02-27 | 2007-02-23 | 4 | Jones Elaine V By EuclidSR Biotechnology Partners L.P. | TRGT | Stock Option (Right to Buy) | I | 0,08 | -197 | 0 | |||||
| 2007-02-27 | 2007-02-23 | 4 | Jones Elaine V By EuclidSR Partners L.P. | TRGT | Stock Option (Right to Buy) | I | 0,08 | -803 | 0 | |||||
| 2007-02-27 | 2007-02-23 | 4 | Jones Elaine V By EuclidSR Biotechnology Partners, L.P. | TRGT | Common Stock | I | 0,0750 | 197 | 0 | 371.945 | ||||
| 2007-02-27 | 2007-02-23 | 4 | Jones Elaine V By EuclidSR Partners, L.P. | TRGT | Common Stock | I | 0,0750 | 803 | 0 | 1.510.883 | ||||
| 2006-08-18 | 3 | BURRILL STEVEN By Burrill Biotechnology Capital Fund L.P. | TRGT | Common Stock | I | 778.062 | ||||||||
| 2006-08-18 | 3 | BURRILL STEVEN By Burrill & Company LLC | TRGT | Common Stock | I | 1.000 | ||||||||
| 2006-05-08 | 2006-04-18 | 4/A | NOMURA INTERNATIONAL PLC Owned by NLP | TRGT | Common Stock | I | 946.428 | 946.428 | ||||||
| 2006-05-08 | 2006-04-18 | 4/A | NOMURA INTERNATIONAL PLC | TRGT | Common Stock | D | 1.190.476 | 2.136.904 | ||||||
| 2006-04-20 | 2006-04-18 | 4 | NOMURA INTERNATIONAL PLC Owned by NLP | TRGT | Series C Convertible Preferred Stock | I | -6.570.248 | 0 | ||||||
| 2006-04-20 | 2006-04-18 | 4 | NOMURA INTERNATIONAL PLC | TRGT | Series C Convertible Preferred Stock | D | -8.264.462 | 0 | ||||||
| 2006-04-20 | 2006-04-18 | 4 | NOMURA INTERNATIONAL PLC Owned by NLP | TRGT | Common Stock | I | 946.428 | 946.428 | ||||||
| 2006-04-20 | 2006-04-18 | 4 | NOMURA INTERNATIONAL PLC | TRGT | Common Stock | D | 1.190.476 | 2.136.904 | ||||||
| 2006-04-11 | 3 | BLIXT CHARLES A By R.J. Reynolds Tobacco Holdings, Inc. | TRGT | Common Stock | I | 4.333 | ||||||||
| 2006-04-11 | 3 | DESOUZA ERROL B | TRGT | Common Stock | D | 1.000 | ||||||||
| 2006-04-11 | 3 | Richard John P | TRGT | Common Stock | D | 4.333 | ||||||||
| 2006-04-11 | 3 | Bencherif Merouane | TRGT | Common Stock | D | 7.735 | ||||||||
| 2006-04-11 | 3 | Caldwell William S | TRGT | Common Stock | D | 7.735 | ||||||||
| 2006-04-11 | 3 | deBethizy J Donald | TRGT | Common Stock | D | 93.835 | ||||||||
| 2006-04-11 | 3 | Dunbar Geoffrey C | TRGT | Common Stock | D | 22.602 | ||||||||
| 2006-04-11 | 3 | HANHAM ANN By Burrill & Company LLC | TRGT | Common Stock | I | 1.000 | ||||||||
| 2006-04-11 | 3 | Musso Alan A | TRGT | Common Stock | D | 2.799 | ||||||||
| 2006-04-11 | 3 | SKALETSKY MARK B | TRGT | Common Stock | D | 11.332 |
